An analysis of administrative data found that proximate clinical event ratios provided a systematic approach to identifying possible iatrogenic risk factors or complications

Journal of Clinical Epidemiology

Volumn 58, Issue 2, 2005, Pages 162-170

  Baine, William B ^a   Kazakova, Sophia V ^a,b  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Coronary disease; Depressive disorder; Epidemiologic methods; Hip fractures; Medicare Part A; Osteoarthritis; Pneumonia, aspiration; Respiratory insufficiency

Indexed keywords

ARTICLE; CEREBROVASCULAR DISEASE; CHOLECYSTECTOMY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DEPRESSION; DISEASE ASSOCIATION; DUODENITIS; FEMUR NECK FRACTURE; GASTRITIS; HOSPITAL ADMISSION; HOSPITAL MANAGEMENT; HOSPITALIZATION; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; OSTEOARTHRITIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK FACTOR; TOTAL KNEE REPLACEMENT;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; DEPRESSION; HIP FRACTURES; HOSPITAL INFORMATION SYSTEMS; HOSPITALIZATION; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MEDICARE; PNEUMONIA, ASPIRATION; RESPIRATORY INSUFFICIENCY; RISK FACTORS;

EID: 12944323177     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2004.08.002     Document Type: Article

References (75)

1. Bureau of Data Management and Strategy, Health Care Financing Administration, US Department of Health and Human Services Glossary Data users reference guide 1997 The Bureau Baltimore, MD 1 7
2. E. Granek, S.P. Baker, H. Abbey, E. Robinson, A.H. Myers, J.S. Samkoff, and L.E. Klein Medications and diagnoses in relation to falls in a long-term care facility J Am Geriatr Soc 35 1987 503 511
3. W.A. Ray, M.R. Griffin, W. Schaffner, D.K. Baugh, and L.J. Melton III Psychotropic drug use and the risk of hip fracture N Engl J Med 316 1987 363 369
4. W.A. Ray, M.R. Griffin, and E. Malcolm Cyclic antidepressants and the risk of hip fracture Arch Intern Med 151 1991 754 756
5. R. Ruthazer, and L.A. Lipsitz Antidepressants and falls among elderly people in long-term care Am J Public Health 83 1993 746 749
6. B. Liu, G. Anderson, N. Mittmann, T. To, T. Axcell, and N. Shear Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people Lancet 351 1998 1303 1307
7. P.B. Thapa, P. Gideon, T.W. Cost, A.B. Milam, and W.A. Ray Antidepressants and the risk of falls among nursing home residents N Engl J Med 339 1998 875 882
8. C.L. Arfken, J.G. Wilson, and S.M. Aronson Retrospective review of selective serotonin reuptake inhibitors and falling in older nursing home residents Int Psychogeriatr 13 2001 85 91
9. K. Kallin, L. Lundin-Olsson, J. Jensen, L. Nyberg, and Y. Gustafson Predisposing and precipitating factors for falls among older people in residential care Public Health 116 2002 263 271
10. M.E. Gluck K.W. Hanson Medicare chartbook 2nd ed. 2001 Henry J. Kaiser Family Foundation Menlo Park, CA 23 40
11. Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, US Department of Health and Human Services. Medical Expenditure Panel Survey. Available at: http://www.meps.ahrq.gov/MEPSNet/HC/ MEPSnetHC.asp. Accessed May 13, 2004.
12. Bureau of Data Management and Strategy, Health Care Financing Administration, US Department of Health and Human Services Overview of the Health Care Financing Administration Data users reference guide 1995 The Bureau Baltimore, MD 1 16
13. Bureau of Data Management and Strategy, Health Care Financing Administration, US Department of Health and Human Services Claims and utilization data Data users reference guide 1997 The Bureau Baltimore, MD 1 198
14. Bureau of Data Management and Strategy, Health Care Financing Administration, US Department of Health and Human Services Enrollment and eligibility data Data users reference guide 1997 The Bureau Baltimore, MD 1 67
15. th Revision, clinical modification. ICD-9-CM. 2001 2000 Medicode Dover, DE
16. J.H. Zar Biostatistical analysis 2nd ed. 1984 Prentice-Hall Englewood Cliffs, NJ p. 369-405
17. J.S. White Tables of normal percentile points J Am Statistical Assoc 65 1970 635 638
18. M.E. Levison Pneumonia, including necrotizing pulmonary infections (lung abscess) E. Braunwald A.S. Fauci D.L. Kasper S.L. Hauser D.L. Longo J.L. Jameson Harrison's principles of internal medicine 15th ed. 2001 McGraw-Hill New York, NY 1475 1485
19. S.O. Dalton, C. Johansen, L. Mellemkjaer, B. Norgard, H.T. Sorensen, and J.H. Olsen Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding. A population-based cohort study Arch Intern Med 163 2003 59 64
20. J. Hallas Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis Epidemiology 7 1996 478 484
21. A.B. Hill Principles of medical statistics 9th ed. 1971 Oxford University Press New York, NY p. 312-20
22. M.S. Kramer, J.M. Leventhal, T.A. Hutchinson, and A.R. Feinstein An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use JAMA 242 1979 623 632
23. D.A. Lane, M.S. Kramer, T.A. Hutchinson, J.K. Jones, and C. Naranjo The causality assessment of adverse drug reactions using a Bayesian approach Pharmaceut Med 2 1987 265 283
24. C.A. Naranjo, U. Busto, E.M. Sellers, P. Sandor, I. Ruiz, E.A. Roberts, E. Janacek, C. Domecq, and D.J. Greenblatt A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 1981 239 245
25. J.J. Gallo, H.K. Armenian, D.E. Ford, W.W. Eaton, and A.S. Khachaturian Major depression and cancer: The 13-year follow-up of the Baltimore Epidemiologic Catchment Area sample Cancer Causes Control 11 2000 751 758
26. Nonsteroidal anti-inflammatory agents Drug facts and comparisons 2003 57th ed. 2002 Facts & Comparisons St. Louis, MO 911 932
27. C.H. Browning Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects Int J Psychiatry Med 26 1996 25 34
28. A. Juby, and P. Davis Psychological profiles of patients with upper gastrointestinal symptomatology induced by non-steroidal anti-inflammatory drugs Ann Rheum Dis 50 1991 211 213
29. R. Rugulies Depression as a predictor for coronary heart disease. A review and meta-analysis Am J Prev Med 23 2002 51 61
30. W.H. Sauer, J.A. Berlin, and S.E. Kimmel Selective serotonin reuptake inhibitors and myocardial infarction Circulation 104 2001 1894 1898
31. E. Lindal, P. Hartharson, J. Magnusson, and H. Alfrethsson A 5-year psycho-medical follow-up study of coronary by-pass artery graft patients Scand J Rehabil Med 28 1996 27 31
32. N. Timberlake, L. Klinger, P. Smith, G. Venn, T. Treasure, M. Harrison, and S.P. Newman Incidence and patterns of depression following coronary artery bypass graft surgery J Psychosom Res 43 1997 197 207
33. R.A. Baker, M.J. Andrew, G. Schrader, and J.L. Knight Preoperative depression and mortality in coronary artery bypass surgery: Preliminary findings ANZ J Surg 71 2001 139 142
34. J.C. Peterson, M.E. Charlson, P. Williams-Russo, K.H. Krieger, P.A. Pirraglia, B.S. Meyers, and G.S. Alexopoulos New postoperative depressive symptoms and long-term cardiac outcomes after coronary artery bypass surgery Am J Geriatr Psychiatry 10 2002 192 198
35. C. Bengtsson, J. Lennartsson, O. Lindquist, H. Noppa, and J. Sigurdsson Sleep disturbances, nightmares and other possible central nervous disturbances in a population sample of women, with special reference to those on antihypertensive drugs Eur J Clin Pharmacol 17 1980 173 177
36. W.P. Koella CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action Eur J Clin Pharmacol 28 Suppl 1985 55 63
37. J. Avorn, D.E. Everitt, and S. Weiss Increased antidepressant use in patients prescribed beta-blockers JAMA 255 1986 357 360
38. B.Q. Thiessen, S.M. Wallace, J.L. Blackburn, T.W. Wilson, and U. Bergman Increased prescribing of antidepressants subsequent to beta-blocker therapy Ann Intern Med 150 1990 2286 2290
39. B.B. Gerstman, H.M. Jolson, M. Bauer, P. Cho, J.M. Livingston, and R. Platt The incidence of depression in new users of beta-blockers and selected antihypertensives J Clin Epidemiol 49 1996 809 815
40. L.D. Reid, B.H. McFarland, R.E. Johnson, and K.K. Brody Beta-blockers and depression: The more the murkier? Ann Pharmacother 32 1998 699 708
41. W. Rathmann, B. Haastert, J.M. Roseman, and G. Giani Cardiovascular drug prescriptions and risk of depression in diabetic patients J Clin Epidemiol 52 1999 1103 1109
42. E.J. Perez-Stable, R. Halliday, P.S. Gardiner, R.B. Baron, W.W. Hauck, M. Acree, and T.J. Coates The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension Am J Med 108 2000 359 365
43. D.T. Ko, P.R. Hebert, C.S. Coffey, A. Sedrakyan, J.P. Curtis, and H.M. Krumholz Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction JAMA 288 2002 351 357
44. J. Fogelman Verapamil may cause depression, confusion, and impotence [Letter] Tex Med 83 1987 8
45. C. Biriell, J. McEwen, and E. Sanz Depression associated with diltiazem [Letter] BMJ 299 1989 796
46. W. Kostowski, W. Dyr, and O. Pucilowski Activity of diltiazem and nifedipine in some animal models of depression Pol J Pharmacol Pharm 42 1990 121 127
47. D.H. Overstreet, O. Pucilowski, A.H. Rezvani, and D.S. Janowsky Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Finders Sensitive Line rats as an animal model of depression Psychopharmacology (Berl) 121 1995 27 37
48. S.B. Patten, J.V. Williams, and E.J. Love Self-reported depressive symptoms in association with medication exposures among medical inpatients: A cross-sectional study Can J Psychiatry 40 1995 264 269
49. V.L. Kozlovskii, and I.V. Prakh'e Vliianie blokatorov kal'tsievykh kanalov na effekty antidepressantov (Russian) [The influence of calcium channel blockers on antidepressant effects.] Eksp Klin Farmakol 59 1996 9 11
50. S.K. Srivastava, and C. Nath The differential effects of calcium channel blockers in the behavioural despair test in mice Pharmacol Res 42 2000 293 297
51. S. Paolucci, G. Antonucci, M.G. Grasso, D. Morelli, E. Troisi, P. Coiro, D. De Angelis, F. Rizzi, and M. Bragoni Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study Cerebrovasc Dis 12 2001 264 271
52. L. Turner-Stokes Poststroke depression: Getting the full picture Lancet 361 2003 1757 1758
53. C.O. McDonnell, I. Bailey, T. Stumpf, T.N. Walsh, and C.D. Johnson The effect of cholecystectomy on plasma cholecystokinin Am J Gastroenterol 97 2002 2189 2192
54. B receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice Eur J Pharmacol 261 1994 257 263
55. A.S. Wells, N.W. Read, K. Uvnas-Moberg, and P. Alster Influences of fat and carbohydrate on postprandial sleepiness, mood, and hormones Physiol Behav 61 1997 679 686
56. A.S. Wells, N.W. Read, M. Fried, J. Borovicka, and M. D'Amato Effects of a specific CCK-A antagonist, Loxiglumide on postprandial mood and sleepiness J Psychopharmacol 11 1997 241 246
57. R.W. Biagi, and B.N. Bapat Intrahepatic obstructive jaundice from amitriptyline Br J Psychiatry 113 1967 1113 1114
58. D. Larrey, G. Amouyal, D. Pessayre, C. Degott, O. Danne, J.P. Machayekhi, G. Feldman, and J.P. Benhamox Amitriptyline-induced prolonged cholestasis Gastroenterology 94 1988 200 203
59. W.B. Baine, W. Yu, and J.P. Summe Epidemiologic trends in the hospitalization of elderly Medicare patients for pneumonia, 1991-1998 Am J Public Health 91 2001 1121 1123
60. S.E. Langmore, K.A. Skarupski, P.S. Park, and B.E. Fries Predictors of aspiration pneumonia in nursing home residents Dysphasia 17 2002 298 307
61. D.L. Ackerman, J. Ünutzer, S. Greenland, and M. Gitlin Inpatient treatment of depression and associated hospital charges Pharmacoepidemiol Drug Saf 11 2002 219 227
62. N. Bonhomme Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review J Clin Psychopharmacol 18 1998 447 454
63. A.A. Nierenberg, D. Dougherty, and J.F. Rosenbaum Dopaminergic agents and stimulants as antidepressant augmentation strategies J Clin Psychiatry 59 Suppl 5 1998 60 64
64. P.S. D'Aquila, M. Collu, G.L. Gessa, and G. Serra The role of dopamine in the mechanism of action of antidepressant drugs Eur J Pharmacol 405 2000 365 373
65. A. Zangen, R. Nakash, D.H. Overstreet, and G. Yadid Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens Psychopharmacology (Berl) 155 2001 434 439
66. J.P. Kessler, and A. Jean Inhibition of the swallowing reflex by local application of serotonergic agents into the nucleus of the solitary tract Eur J Pharmacol 118 1985 77 85
67. J.P. Kessler, and A. Jean Effect of catecholamines on the swallowing reflex after pressure microinjections into the lateral solitary complex of the medulla oblongata Brain Res 386 1986 69 77
68. J.P. Kessler, and A. Jean Inhibitory influence of monoamines and brainstem monoaminergic regions on the medullary swallowing reflex Neurosci Lett 65 1986 41 46
69. S. Sigala, G. Missale, R. Raddino, R. Cestari, L. Lojacono, C. Missale, and P.F. Spano Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat Life Sci 54 1994 1035 1045
70. J.E. Valenzuela, and C.P. Dooley Dopamine antagonists in the upper gastrointestinal tract Scand J Gastroenterol Suppl 96 1984 127 136
71. M. Shannon, and F.H. Lovejoy Jr. Pulmonary consequences of severe tricyclic antidepressant ingestion J Toxicol Clin Toxicol 25 1987 443 461
72. T.M. Roy, M.A. Ossorio, L.M. Cipolla, C.L. Fields, H.L. Snider, and W.H. Anderson Pulmonary complications after tricyclic antidepressant overdose Chest 96 1989 852 856
73. R.M. Varnell, J.D. Godwin, M.L. Richardson, and J.M. Vincent Adult respiratory distress syndrome from overdose of tricyclic antidepressants Radiology 170 1989 667 670
74. Antidepressants Drug facts and comparisons 2003 57th ed. 2002 Facts & Comparisons St. Louis, MO 976 1021
75. J.B. Schwartz Clinical pharmacology W.R. Hazzard J.P. Blass W.H. Ettinger Jr. J.B. Halter J.G. Ouslander Principles of geriatric medicine and gerontology 4th ed. 1999 McGraw-Hill New York, NY 302 331